Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Chemoradiation and Surgery for Esophageal Cancer
NCT00570531Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jun 2007
- Primary completion
- Oct 2010
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in esophageal cancer, sponsored by University of Michigan Rogel Cancer Center. Started Jun 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00570531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570531.